BioWorld MedTech

May 15, 2012

MedTech Investing Conference: Changing partnership models reflect new paths to business

MINNEAPOLIS Things go in cycles, they say. That certainly appears to be true insofar as pharmaceutical company ownership of medical device companies is concerned. Read More

HRS 2012: New AF mapping technology data may finally silence the skeptics

Maquet wins FDA clearance for new MEGA IAB catheters

Washington roundup: Authors hint 'multi-specialty' needed for knee replacements

Report from Europe: Boston Scientific receives CE mark for Innova BMS system

Coming Wednesday in MDD Perspectives

Agreements/contracts: Philips to sell Boston Sci cath imaging equipment

Financings roundup: Regentis raises $10M for knee cartilage regeneration product

Patent watch: Excelsior Medical gains patents for antiseptic cap technology

Court report: ICU Medical to seek damages in wake of victory over RyMed

Med-Tech Notes: Boston Sci offers warranties on defibrillators

Product Briefs

People in the News

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 12, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...

Illustration of head with maze that is missing parts

CTAD 2025: The challenges of combination therapies for dementia

BioWorld Science

At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...